These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18937663)

  • 1. Drug-induced Sweet's syndrome secondary to hepatitis C antiviral therapy.
    Gheorghe L; Cotruta B; Trifu V; Cotruta C; Becheanu G; Gheorghe C
    Int J Dermatol; 2008 Sep; 47(9):957-9. PubMed ID: 18937663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature.
    Hurst EA; Mauro T
    Arch Dermatol; 2005 Jul; 141(7):865-8. PubMed ID: 16027302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease and treatment outcome in chronic active hepatitis C with occult HBV infection.
    Berberova M; Mendizova A; Popchristova E; Krastev N; Genov J
    Hepatogastroenterology; 2003; 50(54):2009-12. PubMed ID: 14696454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.
    Lee SD; Yu ML; Cheng PN; Lai MY; Chao YC; Hwang SJ; Chang WY; Chang TT; Hsieh TY; Liu CJ; Chen DS
    J Viral Hepat; 2005 May; 12(3):283-91. PubMed ID: 15850469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
    Bolukbas C; Bolukbas FF; Kebdir T; Canayaz L; Dalay AR; Kilic G; Ovunc O
    Acta Gastroenterol Belg; 2005; 68(4):432-4. PubMed ID: 16432996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C.
    Mangia A; Ricci GL; Persico M; Minerva N; Carretta V; Bacca D; Cela M; Piattelli M; Annese M; Maio G; Conte D; Guadagnino V; Pazienza V; Festi D; Spirito F; Andriulli A
    J Viral Hepat; 2005 May; 12(3):292-9. PubMed ID: 15850470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
    Enjoji M; Dainichi T; Gondo H; Urabe K
    Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C.
    Taliani G; Biliotti E; Capanni M; Tozzi A; Bresci S; Pimpinelli N
    J Chemother; 2005 Apr; 17(2):212-4. PubMed ID: 15920908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sweet's syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid.
    Park CJ; Bae YD; Choi JY; Heo PS; Lee KS; Park YS; Lee JA
    Korean J Intern Med; 2001 Sep; 16(3):218-21. PubMed ID: 11769583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.
    Yaşar B; Yaşar Ş; Güneş P
    Turk J Gastroenterol; 2015 Mar; 26(2):189-90. PubMed ID: 25835121
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C.
    Baker RD; Dee D; Baker SS
    J Clin Gastroenterol; 2007 Jan; 41(1):111-4. PubMed ID: 17198073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT.
    Jacobson IM; Ahmed F; Russo MW; Lebovics E; Dieterich DT; Esposito SP; Bach N; Klion F; Tobias H; Antignano L; Brown RS; Gabbaizadeh D; Geders J; Levendoglu H
    Am J Gastroenterol; 2004 Sep; 99(9):1700-5. PubMed ID: 15330905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and tolerability of pegylated Interferon alpha-2a and ribavirin combination therapy in Romanian patients with chronic hepatitis C: from clinical trials to clinical practice.
    Gheorghe L; Grigorescu M; Iacob S; Damian D; Gheorghe C; Iacob R; Simionov I; Vadan R; Parvulescu I; Bancila I
    Rom J Gastroenterol; 2005 Jun; 14(2):109-15. PubMed ID: 15990928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis C treatment. Side effects and their management.
    Shobokshi OA; Tantawe AO; Al-Kayyal BM
    Saudi Med J; 2003 Jul; 24 Suppl 2():S76-8. PubMed ID: 12897905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 16. Pegylated interferon and ribavirin in haemodialysis patients.
    Bruchfeld A; Lindahl K; Reichard O; Carlsson T; Schvarcz R
    Nephrol Dial Transplant; 2006 May; 21(5):1444-5; author reply 1445-6. PubMed ID: 16517569
    [No Abstract]   [Full Text] [Related]  

  • 17. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sweet's syndrome--like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia.
    Jagdeo J; Campbell R; Long T; Muglia J; Telang G; Robinson-Bostom L
    J Am Acad Dermatol; 2007 Apr; 56(4):690-3. PubMed ID: 17367621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience.
    Sood A; Midha V; Hissar S; Kumar M; Suneetha PV; Bansal M; Sood N; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2008 Feb; 23(2):203-7. PubMed ID: 17645472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.